David A. Siegel Astrazeneca PLC Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Astrazeneca PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 86,100 shares of AZN stock, worth $6.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

86,100

Holding current value

$6.39 Million

% of portfolio

0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $5.44 Million - $6.85 Million	86,100 New	86,100 $5.64 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $8.61 Million - $10.4 Million	-128,900 Reduced 6.99%	1,714,100 $134 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $75.6 Million - $86.2 Million	1,239,300 Added 205.28%	1,843,000 $125 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $5.86 Million - $6.56 Million	94,700 Added 18.61%	603,700 $40.7 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $32 Million - $35.3 Million	492,800 Added 3041.98%	509,000 $34.5 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $713,082 - $773,262	-10,200 Reduced 38.64%	16,200 $1.16 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $19.8 Million - $22.4 Million	-312,900 Reduced 92.22%	26,400 $1.83 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $15.8 Million - $20.6 Million	292,300 Added 621.91%	339,300 $23 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1.55 Million - $3.96 Million	29,200 Added 164.04%	47,000 $2.58 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $6.63 Million - $7.95 Million	-111,800 Reduced 86.27%	17,800 $1.18 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $7.22 Million - $8.7 Million	129,600 New	129,600 $8.6 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $2.23 Million - $2.44 Million	-40,100 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $1.94 Million - $2.41 Million	40,100 New	40,100 $2.4 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $4.47 Million - $5.16 Million	-94,800 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $37.2 Million - $44.5 Million	-766,800 Reduced 89.0%	94,800 $4.74 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $3.69 Million - $4.25 Million	69,600 Added 8.79%	861,600 $47.2 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $34.1 Million - $43.8 Million	792,000 New	792,000 $41.9 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $3.04 Million - $4.13 Million	-80,500 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $1.81 Million - $2.15 Million	-42,600 Reduced 34.61%	80,500 $4.01 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $6.9 Million - $7.82 Million	-171,900 Reduced 58.27%	123,100 $5.49 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $11 Million - $12.3 Million	295,000 New	295,000 $12.2 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $4.53 Million - $5.1 Million	-123,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $3.91 Million - $4.46 Million	112,400 Added 1060.38%	123,000 $4.87 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $5.09 Million - $5.45 Million	-147,200 Reduced 93.28%	10,600 $372,000
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $6.83 Million - $7.59 Million	-207,300 Reduced 56.78%	157,800 $5.52 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $240,675 - $260,850	-7,500 Reduced 2.01%	365,100 $12.7 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $10.8 Million - $12.7 Million	372,600	372,600 $12.6 Million

Others Institutions Holding AZN

# of Institutions

1,356

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account